Abstract
Ischemic stroke (IS) is the leading cause of acquired disability and the second leading cause of dementia and mortality. Current treatments for IS are primarily focused on revascularization of the occluded artery. However, only 10% of patients are eligible for revascularization and 50% of revascularized patients remain disabled at 3 months. Accumulating evidence highlight the prognostic significance of the neuro- and thrombo-inflammatory response after IS. However, several randomized trials of promising immunosuppressive or immunomodulatory drugs failed to show positive results. Insufficient understanding of inter-patient variability in the cellular, functional, and spatial organization of the inflammatory response to IS likely contributed to the failure to translate preclinical findings into successful clinical trials. The inflammatory response to IS involves complex interactions between neuronal, glial, and immune cell subsets across multiple immunological compartments, including the blood-brain barrier, the meningeal lymphatic vessels, the choroid plexus, and the skull bone marrow. Here, we review the neuro- and thrombo-inflammatory responses to IS. We discuss how clinical imaging and single-cell omic technologies have refined our understanding of the spatial organization of pathobiological processes driving clinical outcomes in patients with an IS. We also introduce recent developments in machine learning statistical methods for the integration of multi-omic data (biological and radiological) to identify patient-specific inflammatory states predictive of IS clinical outcomes.
Similar content being viewed by others
Abbreviations
- AIS:
-
Acute ischemic stroke
- ASL:
-
Arterial spin labeling
- BBB:
-
Blood-brain barrier
- CNS:
-
Central nervous system
- CSF:
-
Cerebrospinal fluid
- ChP:
-
Choroid plexus
- EVT:
-
Endovascular therapy
- FLAIR:
-
Fluid attenuated inversion recovery
- HARM:
-
Hyperintense acute reperfusion marker
- ICH:
-
Intracranial hemorrhage
- IL:
-
Interleukin
- IVT:
-
Intravenous thrombolysis
- mLVs:
-
Meningeal lymphatic vessels
- MS:
-
Multiple sclerosis
- MRI:
-
Magnetic resonance imaging
- NMOSD:
-
Neuromyelitis optica spectrum disorders
- PET:
-
Positron emission tomography
- SDF-1:
-
Stroma cell-derived factor 1
References
Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, Fisher M, Pandian J, Lindsay P (2022) World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke 17(1):18–29
Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Davalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723–1731
Iadecola C, Buckwalter MS, Anrather J (2020) Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest 130(6):2777–2788
Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD (2019) Global brain inflammation in stroke. Lancet Neurol 18(11):1058–1066
Chamorro A, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R (2012) The immunology of acute stroke. Nat Rev Neurol 8(7):401–410
De Meyer SF, Langhauser F, Haupeltshofer S, Kleinschnitz C, Casas AI (2022) Thromboinflammation in brain ischemia: recent updates and future perspectives. Stroke 53(5):1487–1499
Dreikorn M, Milacic Z, Pavlovic V, Meuth SG, Kleinschnitz C, Kraft P (2018) Immunotherapy of experimental and human stroke with agents approved for multiple sclerosis: a systematic review. Ther Adv Neurol Disord 11:1756286418770626
Buckley MW, McGavern DB (2022) Immune dynamics in the CNS and its barriers during homeostasis and disease. Immunol Rev 306(1):58–75
Alves de Lima K, Rustenhoven J, Kipnis J (2020) Meningeal immunity and its function in maintenance of the central nervous system in health and disease. Annu Rev Immunol 38:597–620
Croese T, Castellani G, Schwartz M (2021) Immune cell compartmentalization for brain surveillance and protection. Nat Immunol 22(9):1083–1092
Giladi A, Amit I (2018) Single-cell genomics: a stepping stone for future immunology discoveries. Cell 172(1–2):14–21
Medawar PB (1948) Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29(1):58–69
Rustenhoven J, Drieu A, Mamuladze T, de Lima KA, Dykstra T, Wall M, Papadopoulos Z, Kanamori M, Salvador AF, Baker W, Lemieux M, Da Mesquita S, Cugurra A, Fitzpatrick J, Sviben S, Kossina R, Bayguinov P, Townsend RR, Zhang Q et al (2021) Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184(4):1000–1016
Candelario-Jalil E, Dijkhuizen RM, Magnus T (2022) Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke 53(5):1473–1486
Mundt S, Greter M, Flugel A, Becher B (2019) The CNS immune landscape from the viewpoint of a T cell. Trends Neurosci 42(10):667–679
Mrdjen D, Pavlovic A, Hartmann FJ, Schreiner B, Utz SG, Leung BP, Lelios I, Heppner FL, Kipnis J, Merkler D, Greter M, Becher B (2018) High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48(2):380–395
Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523(7560):337–341
Alves de Lima K, Rustenhoven J, Da Mesquita S, Wall M, Salvador AF, Smirnov I, Martelossi Cebinelli G, Mamuladze T, Baker W, Papadopoulos Z, Lopes MB, Cao WS, Xie XS, Herz J, Kipnis J (2020) Meningeal gammadelta T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat Immunol 21(11):1421–1429
Filiano AJ, Gadani SP, Kipnis J (2017) How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci 18(6):375–384
Ribeiro M, Brigas HC, Temido-Ferreira M, Pousinha PA, Regen T, Santa C, Coelho JE, Marques-Morgado I, Valente CA, Omenetti S, Stockinger B, Waisman A, Manadas B, Lopes LV, Silva-Santos B, Ribot JC (2019) Meningeal gammadelta T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci Immunol 4(40):eaay5199
Lin Y, Zhang JC, Yao CY, Wu Y, Abdelgawad AF, Yao SL, Yuan SY (2016) Critical role of astrocytic interleukin-17 A in post-stroke survival and neuronal differentiation of neural precursor cells in adult mice. Cell Death Dis 7(6):e2273
Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5(1):49–55
Mastorakos P, Mihelson N, Luby M, Burks SR, Johnson K, Hsia AW, Witko J, Frank JA, Latour L, McGavern DB (2021) Temporally distinct myeloid cell responses mediate damage and repair after cerebrovascular injury. Nat Neurosci 24(2):245–258
Russo MV, McGavern DB (2016) Inflammatory neuroprotection following traumatic brain injury. Science 353(6301):783–785
Mundt S, Mrdjen D, Utz SG, Greter M, Schreiner B, Becher B (2019) Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation. Sci Immunol 4(31)
Herisson F, Frodermann V, Courties G, Rohde D, Sun Y, Vandoorne K, Wojtkiewicz GR, Masson GS, Vinegoni C, Kim J, Kim DE, Weissleder R, Swirski FK, Moskowitz MA, Nahrendorf M (2018) Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat Neurosci 21(9):1209–1217
Mazzitelli JA, Smyth LCD, Cross KA, Dykstra T, Sun J, Du S, Mamuladze T, Smirnov I, Rustenhoven J, Kipnis J (2022) Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels. Nat Neurosci 25(5):555–560
Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T (2009) Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40(5):1849–1857
Gelderblom M, Weymar A, Bernreuther C, Velden J, Arunachalam P, Steinbach K, Orthey E, Arumugam TV, Leypoldt F, Simova O, Thom V, Friese MA, Prinz I, Holscher C, Glatzel M, Korn T, Gerloff C, Tolosa E, Magnus T (2012) Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 120(18):3793–3802
Gelderblom M, Gallizioli M, Ludewig P, Thom V, Arunachalam P, Rissiek B, Bernreuther C, Glatzel M, Korn T, Arumugam TV, Sedlacik J, Gerloff C, Tolosa E, Planas AM, Magnus T (2018) IL-23 (interleukin-23)-producing conventional dendritic cells control the detrimental IL-17 (interleukin-17) response in stroke. Stroke 49(1):155–164
Benakis C, Brea D, Caballero S, Faraco G, Moore J, Murphy M, Sita G, Racchumi G, Ling L, Pamer EG, Iadecola C, Anrather J (2016) Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med 22(5):516–523
Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, Schwarz T, Austinat M, Nieswandt B, Wiendl H, Stoll G (2010) Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 115(18):3835–3842
Tsai AS, Berry K, Beneyto MM, Gaudilliere D, Ganio EA, Culos A, Ghaemi MS, Choisy B, Djebali K, Einhaus JF, Bertrand B, Tanada A, Stanley N, Fallahzadeh R, Baca Q, Quach LN, Osborn E, Drag L, Lansberg MG et al (2019) A year-long immune profile of the systemic response in acute stroke survivors. Brain 142(4):978–991
Lambertsen KL, Biber K, Finsen B (2012) Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 32(9):1677–1698
Doyle KP, Quach LN, Sole M, Axtell RC, Nguyen TV, Soler-Llavina GJ, Jurado S, Han J, Steinman L, Longo FM, Schneider JA, Malenka RC, Buckwalter MS (2015) B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci 35(5):2133–2145
Benakis C, Llovera G, Liesz A (2018) The meningeal and choroidal infiltration routes for leukocytes in stroke. Ther Adv Neurol Disord 11:1756286418783708
Perez-de-Puig I, Miro-Mur F, Ferrer-Ferrer M, Gelpi E, Pedragosa J, Justicia C, Urra X, Chamorro A, Planas AM (2015) Neutrophil recruitment to the brain in mouse and human ischemic stroke. Acta Neuropathol 129(2):239–257
Eash KJ, Greenbaum AM, Gopalan PK, Link DC (2010) CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest 120(7):2423–2431
Gaffen SL, Jain R, Garg AV, Cua DJ (2014) The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14(9):585–600
Llovera G, Benakis C, Enzmann G, Cai R, Arzberger T, Ghasemigharagoz A, Mao X, Malik R, Lazarevic I, Liebscher S, Erturk A, Meissner L, Vivien D, Haffner C, Plesnila N, Montaner J, Engelhardt B, Liesz A (2017) The choroid plexus is a key cerebral invasion route for T cells after stroke. Acta Neuropathol 134(6):851–868
Desilles JP, Loyau S, Syvannarath V, Gonzalez-Valcarcel J, Cantier M, Louedec L, Lapergue B, Amarenco P, Ajzenberg N, Jandrot-Perrus M, Michel JB, Ho-Tin-Noe B, Mazighi M (2015) Alteplase reduces downstream microvascular thrombosis and improves the benefit of large artery recanalization in stroke. Stroke 46(11):3241–3248
Desilles JP, Syvannarath V, Di Meglio L, Ducroux C, Boisseau W, Louedec L, Jandrot-Perrus M, Michel JB, Mazighi M, Ho-Tin-Noe B (2018) Downstream microvascular thrombosis in cortical venules is an early response to proximal cerebral arterial occlusion. J Am Heart Assoc 7(5)
Desilles JP, Syvannarath V, Ollivier V, Journe C, Delbosc S, Ducroux C, Boisseau W, Louedec L, Di Meglio L, Loyau S, Jandrot-Perrus M, Potier L, Michel JB, Mazighi M, Ho-Tin-Noe B (2017) Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation. Stroke 48(7):1932–1940
Maier B, Desilles JP, Mazighi M (2020) Intracranial hemorrhage after reperfusion therapies in acute ischemic stroke patients. Front Neurol 11(1666):599908
Maestrini I, Tagzirt M, Gautier S, Dupont A, Mendyk AM, Susen S, Tailleux A, Vallez E, Staels B, Cordonnier C, Leys D, Bordet R (2020) Analysis of the association of MPO and MMP-9 with stroke severity and outcome: cohort study. Neurology 95(1):e97–e108
Tay A, Tamam Y, Yokus B, Ustundag M, Orak M (2015) Serum myeloperoxidase levels in predicting the severity of stroke and mortality in acute ischemic stroke patients. Eur Rev Med Pharmacol Sci 19(11):1983–1988
Laridan E, Denorme F, Desender L, Francois O, Andersson T, Deckmyn H, Vanhoorelbeke K, De Meyer SF (2017) Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol 82(2):223–232
Grosse GM, Blume N, Abu-Fares O, Gotz F, Ernst J, Leotescu A, Gabriel MM, van Gemmeren T, Worthmann H, Lichtinghagen R, Imker R, Falk CS, Weissenborn K, Schuppner R, de Buhr N (2022) Endogenous deoxyribonuclease activity and cell-free deoxyribonucleic acid in acute ischemic stroke: a cohort study. Stroke 53(4):1235–1244
Martinod K, Wagner DD (2014) Thrombosis: tangled up in NETs. Blood 123(18):2768–2776
Di Meglio L, Desilles JP, Ollivier V, Nomenjanahary MS, Di Meglio S, Deschildre C, Loyau S, Olivot JM, Blanc R, Piotin M, Bouton MC, Michel JB, Jandrot-Perrus M, Ho-Tin-Noe B, Mazighi M (2019) Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis. Neurology 93(18):e1686–e1698
Renu A, Millan M, San Roman L, Blasco J, Marti-Fabregas J, Terceno M, Amaro S, Serena J, Urra X, Laredo C, Barranco R, Camps-Renom P, Zarco F, Oleaga L, Cardona P, Castano C, Macho J, Cuadrado-Godia E, Vivas E et al (2022) Investigators, Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial. JAMA 327(9):826–835
Liesz A, Hu X, Kleinschnitz C, Offner H (2015) Functional role of regulatory lymphocytes in stroke: facts and controversies. Stroke 46(5):1422–1430
Schwartz M, Kipnis J (2004) Self and non-self discrimination is needed for the existence rather than deletion of autoimmunity: the role of regulatory T cells in protective autoimmunity. Cell Mol Life Sci 61(18):2285–2289
Baruch K, Deczkowska A, Rosenzweig N, Tsitsou-Kampeli A, Sharif AM, Matcovitch-Natan O, Kertser A, David E, Amit I, Schwartz M (2016) PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer’s disease. Nat Med 22(2):135–137
Bodhankar S, Chen Y, Lapato A, Dotson AL, Wang J, Vandenbark AA, Saugstad JA, Offner H (2015) PD-L1 monoclonal antibody treats ischemic stroke by controlling central nervous system inflammation. Stroke 46(10):2926–2934
Desilles JP, Rouchaud A, Labreuche J, Meseguer E, Laissy JP, Serfaty JM, Lapergue B, Klein IF, Guidoux C, Cabrejo L, Sirimarco G, Lavallee PC, Schouman-Claeys E, Amarenco P, Mazighi M (2013) Blood-brain barrier disruption is associated with increased mortality after endovascular therapy. Neurology 80(9):844–851
Bivard A, Kleinig T, Churilov L, Levi C, Lin L, Cheng X, Chen C, Aviv R, Choi PMC, Spratt NJ, Butcher K, Dong Q, Parsons M (2020) Permeability measures predict hemorrhagic transformation after ischemic stroke. Ann Neurol 88(3):466–476
Leigh R, Christensen S, Campbell BC, Marks MP, Albers GW, Lansberg MG, Investigators D (2016) Pretreatment blood-brain barrier disruption and post-endovascular intracranial hemorrhage. Neurology 87(3):263–269
Rubiera M, Garcia-Tornel A, Olive-Gadea M, Campos D, Requena M, Vert C, Pagola J, Rodriguez-Luna D, Muchada M, Boned S, Rodriguez-Villatoro N, Juega J, Deck M, Sanjuan E, Hernandez D, Pinana C, Tomasello A, Molina CA, Ribo M (2020) Computed tomography perfusion after thrombectomy: an immediate surrogate marker of outcome after recanalization in acute stroke. Stroke 51(6):1736–1742
Hom J, Dankbaar JW, Soares BP, Schneider T, Cheng SC, Bredno J, Lau BC, Smith W, Dillon WP, Wintermark M (2011) Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am J Neuroradiol 32(1):41–48
Simpkins AN, Dias C, Leigh R, I. (2016) National Institutes of Health Natural History of Stroke, Identification of reversible disruption of the human blood-brain barrier following acute ischemia. Stroke 47(9):2405–2408
Yu S, Liebeskind DS, Dua S, Wilhalme H, Elashoff D, Qiao XJ, Alger JR, Sanossian N, Starkman S, Ali LK, Scalzo F, Lou X, Yoo B, Saver JL, Salamon N, Wang DJ, Investigators US (2015) Postischemic hyperperfusion on arterial spin labeled perfusion MRI is linked to hemorrhagic transformation in stroke. J Cereb Blood Flow Metab 35(4):630–637
Ng FC, Churilov L, Yassi N, Kleinig TJ, Thijs V, Wu TY, Shah DG, Dewey HM, Sharma G, Desmond PM, Yan B, Parsons MW, Donnan GA, Davis SM, Mitchell PJ, Leigh R, Campbell BCV, Part E-IT (2022) Investigators, Microvascular dysfunction in blood-brain barrier disruption and hypoperfusion within the infarct posttreatment are associated with cerebral edema. Stroke 53(5):1597–1605
Rouchaud A, Pistocchi S, Blanc R, Engrand N, Bartolini B, Piotin M (2014) Predictive value of flat-panel CT for haemorrhagic transformations in patients with acute stroke treated with thrombectomy. J Neurointerv Surg 6(2):139–143
Warach S, Latour LL (2004) Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 35(11 Suppl 1):2659–2661
Nadareishvili Z, Luby M, Leigh R, Shah J, Lynch JK, Hsia AW, Benson RT, Latour LL (2018) An MRI hyperintense acute reperfusion marker is related to elevated peripheral monocyte count in acute ischemic stroke. J Neuroimaging 28(1):57–60
Verheggen ICM, Freeze WM, de Jong JJA, Jansen JFA, Postma AA, van Boxtel MPJ, Verhey FRJ, Backes WH (2021) Application of contrast-enhanced magnetic resonance imaging in the assessment of blood-cerebrospinal fluid barrier integrity. Neurosci Biobehav Rev 127:171–183
Anderson VC, Tagge IJ, Doud A, Li X, Springer CS Jr, Quinn JF, Kaye JA, Wild KV, Rooney WD (2022) DCE-MRI of brain fluid barriers: in vivo water cycling at the human choroid plexus. Tissue Barriers 10(1):1963143
Evans PG, Sokolska M, Alves A, Harrison IF, Ohene Y, Nahavandi P, Ismail O, Miranda E, Lythgoe MF, Thomas DL, Wells JA (2020) Non-invasive MRI of blood-cerebrospinal fluid barrier function. Nat Commun 11(1):2081
Klistorner S, Barnett MH, Parratt J, Yiannikas C, Graham SL, Klistorner A (2022) Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy. Ann Clin Transl Neurol 9(10):1528–1537
Egorova N, Gottlieb E, Khlif MS, Spratt NJ, Brodtmann A (2019) Choroid plexus volume after stroke. Int J Stroke 14(9):923–930
Ricigliano VAG, Morena E, Colombi A, Tonietto M, Hamzaoui M, Poirion E, Bottlaender M, Gervais P, Louapre C, Bodini B, Stankoff B (2021) Choroid plexus enlargement in inflammatory multiple sclerosis: 3.0-T MRI and translocator protein PET evaluation. Radiology 301(1):166–177
Choi JD, Moon Y, Kim HJ, Yim Y, Lee S, Moon WJ (2022) Choroid plexus volume and permeability at brain MRI within the Alzheimer disease clinical spectrum. Radiology 304(3):635–645
Huang J, Tong J, Zhang P, Zhou Y, Li Y, Tan S, Wang Z, Yang F, Kochunov P, Chiappelli J, Tian B, Tian L, Hong LE, Tan Y (2022) Elevated salivary kynurenic acid levels related to enlarged choroid plexus and severity of clinical phenotypes in treatment-resistant schizophrenia. Brain Behav Immun 106:32–39
Eide PK, Valnes LM, Pripp AH, Mardal KA, Ringstad G (2020) Delayed clearance of cerebrospinal fluid tracer from choroid plexus in idiopathic normal pressure hydrocephalus. J Cereb Blood Flow Metab 40(9):1849–1858
Fleischer V, Gonzalez-Escamilla G, Ciolac D, Albrecht P, Kury P, Gruchot J, Dietrich M, Hecker C, Muntefering T, Bock S, Oshaghi M, Radetz A, Cerina M, Kramer J, Wachsmuth L, Faber C, Lassmann H, Ruck T, Meuth SG et al (2021) Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans. Proc Natl Acad Sci USA 118(36)
Cogo A, Mangin G, Maier B, Callebert J, Mazighi M, Chabriat H, Launay JM, Huberfeld G, Kubis N (2021) Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline. Mol Neurodegener 16(1):7
Absinta M, Ha SK, Nair G, Sati P, Luciano NJ, Palisoc M, Louveau A, Zaghloul KA, Pittaluga S, Kipnis J, Reich DS (2017) Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. Elife 6
Ringstad G, Eide PK (2020) Cerebrospinal fluid tracer efflux to parasagittal dura in humans. Nat Commun 11(1):354
Jacob L, de Brito Neto J, Lenck S, Corcy C, Benbelkacem F, Geraldo LH, Xu Y, Thomas JM, El Kamouh MR, Spajer M, Potier MC, Haik S, Kalamarides M, Stankoff B, Lehericy S, Eichmann A, J.L. (2022) Thomas, Conserved meningeal lymphatic drainage circuits in mice and humans. J Exp Med 219(8)
Zhou Y, Cai J, Zhang W, Gong X, Yan S, Zhang K, Luo Z, Sun J, Jiang Q, Lou M (2020) Impairment of the glymphatic pathway and putative meningeal lymphatic vessels in the aging human. Ann Neurol 87(3):357–369
Ding XB, Wang XX, Xia DH, Liu H, Tian HY, Fu Y, Chen YK, Qin C, Wang JQ, Xiang Z, Zhang ZX, Cao QC, Wang W, Li JY, Wu E, Tang BS, Ma MM, Teng JF, Wang XJ (2021) Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson’s disease. Nat Med 27(3):411–418
Wang X, Tian H, Liu H, Liang D, Qin C, Zhu Q, Meng L, Fu Y, Xu S, Zhai Y, Ding X, Wang X (2021) Impaired meningeal lymphatic flow in NMOSD patients with acute attack. Front Immunol 12:692051
Yanev P, Poinsatte K, Hominick D, Khurana N, Zuurbier KR, Berndt M, Plautz EJ, Dellinger MT, Stowe AM (2020) Impaired meningeal lymphatic vessel development worsens stroke outcome. J Cereb Blood Flow Metab 40(2):263–275
Gerhard A, Schwarz J, Myers R, Wise R, Banati RB (2005) Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage 24(2):591–595
Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, Jones T, Kreutzberg GW, Banati RB (2000) Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology 55(7):1052–1054
Price CJ, Wang D, Menon DK, Guadagno JV, Cleij M, Fryer T, Aigbirhio F, Baron JC, Warburton EA (2006) Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke 37(7):1749–1753
Morris RS, Simon Jones P, Alawneh JA, Hong YT, Fryer TD, Aigbirhio FI, Warburton EA, Baron JC (2018) Relationships between selective neuronal loss and microglial activation after ischaemic stroke in man. Brain 141(7):2098–2111
Gauberti M, De Lizarrondo SM, Vivien D (2016) The “inflammatory penumbra” in ischemic stroke: from clinical data to experimental evidence. Eur Stroke J 1(1):20–27
Ringstad G, Eide PK (2022) Molecular trans-dural efflux to skull bone marrow in humans with CSF disorders. Brain 145(4):1464–1472
Androvic P, Kirdajova D, Tureckova J, Zucha D, Rohlova E, Abaffy P, Kriska J, Valny M, Anderova M, Kubista M, Valihrach L (2020) Decoding the transcriptional response to ischemic stroke in young and aged mouse brain. Cell Rep 31(11):107777
Schurch CM, Bhate SS, Barlow GL, Phillips DJ, Noti L, Zlobec I, Chu P, Black S, Demeter J, McIlwain DR, Kinoshita S, Samusik N, Goltsev Y, Nolan GP (2020) Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell 182(5):1341–1359 e19
McCaffrey EF, Donato M, Keren L, Chen Z, Delmastro A, Fitzpatrick MB, Gupta S, Greenwald NF, Baranski A, Graf W, Kumar R, Bosse M, Fullaway CC, Ramdial PK, Forgo E, Jojic V, Van Valen D, Mehra S, Khader SA et al (2022) The immunoregulatory landscape of human tuberculosis granulomas. Nat Immunol 23(2):318–329
Damond N, Engler S, Zanotelli VRT, Schapiro D, Wasserfall CH, Kusmartseva I, Nick HS, Thorel F, Herrera PL, Atkinson MA, Bodenmiller B (2019) A map of human type 1 diabetes progression by imaging mass cytometry. Cell Metab 29(3):755–768 e5
Dunkler D, Sanchez-Cabo F, Heinze G (2011) Statistical analysis principles for omics data. Methods Mol Biol 719:113–131
Tibshirani R, Hastie T, Friedman J (2009) The elements of statistical learning: data mining, inference, and prediction. Springer, New York
Tibshirani R (1996) Regression shrinkage and selection via the lasso, Journal of the Royal Statistical Society. Series B (Methodological) 58(1):267–288
Ghaemi MS, DiGiulio DB, Contrepois K, Callahan B, Ngo TTM, Lee-McMullen B, Lehallier B, Robaczewska A, McIlwain D, Rosenberg-Hasson Y, Wong RJ, Quaintance C, Culos A, Stanley N, Tanada A, Tsai A, Gaudilliere D, Ganio E, Han X et al (2019) Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy. Bioinformatics 35(1):95–103
Culos A, Tsai AS, Stanley N, Becker M, Ghaemi MS, McIlwain DR, Fallahzadeh R, Tanada A, Nassar H, Espinosa C, Xenochristou M, Ganio E, Peterson L, Han X, Stelzer IA, Ando K, Gaudilliere D, Phongpreecha T, Maric I et al (2020) Integration of mechanistic immunological knowledge into a machine learning pipeline improves predictions. Nat Mach Intell 2(10):619–628
Ding DY, Li S, Narasimhan B, Tibshirani R (2022) Cooperative learning for multiview analysis. Proc Natl Acad Sci U S A 119(38):e2202113119
Yin Q, Hung SC, Rathmell WK, Shen L, Wang L, Lin W, Fielding JR, Khandani AH, Woods ME, Milowsky MI, Brooks SA, Wallen EM, Shen D (2018) Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma. Clin Radiol 73(9):782–791
Chaddad A, Daniel P, Sabri S, Desrosiers C, Abdulkarim B (2019) Integration of radiomic and multi-omic analyses predicts survival of newly diagnosed IDH1 wild-type glioblastoma. Cancers (Basel) 11(8)
Zanfardino M, Franzese M, Pane K, Cavaliere C, Monti S, Esposito G, Salvatore M, Aiello M (2019) Bringing radiomics into a multi-omics framework for a comprehensive genotype-phenotype characterization of oncological diseases. J Transl Med 17(1):337
Acknowledgements
We thank Dyani Gaudilliere for providing her scientific input and editing the manuscript.
Funding
This work was supported in part by the National Institute of Health (NIH) R35GM137936, P01HD106414 (BG), the Precision Health and Integrated Diagnosis Center, and the Center for Human Systems Immunology at Stanford (BG). This work was also supported by INSERM and by public grants overseen by the French National Research Agency (ANR) as part of the Investments for the Future program (PIA) under grant agreement No. ANR-18-RHUS-0001 (RHU Booster) and ANR-ETHERISCH.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
MM declares institutional fees for teaching presentations from Boerhinger Ingelheim, Medtronic, Amgen, and consulting fees from Boerhinger Ingelheim, Acticor Biotech, and Air liquide. MM received a grant from the French National Research Agency (ANR) as part of the Investments for the future program (PIA) (grant agreement no. ANR-18-RHUS-0001) for the BOOSTER (Brain clOt persOnalized therapeutic Strategies for sTroke Emergent Reperfusion) consortium. BG declares consulting fees from Surge2surgery. JMO declares institutional fees for teaching presentation for Boehringer Ingelheim and Bristol Myers Squibb; Consulting fees from Abbvie, Acticor, and Bioxodes.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is a contribution to the special issue on: Single-cell and spatial multi-omics in clinical outcomes studies - Guest Editor: Brice Gaudillière
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Maïer, B., Tsai, A.S., Einhaus, J.F. et al. Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke. Semin Immunopathol 45, 125–143 (2023). https://doi.org/10.1007/s00281-023-00984-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-023-00984-6